- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
- To assess the efficacy of multiple oral doses of AFQ056 in reducing the global score of the Aberrant Behavior Checklist – Community Edition (ABC-C) in FXS patients. - To assess the safety and tolerability of multiple titrated oral doses of AFQ056 in FXS patients.
Critère d'inclusion
- Fragile X syndrome